Elevated Plasma Soluble Triggering Receptor Expressed on Myeloid Cells-1 Level in Patients with Acute Coronary Syndrome (ACS): A Biomarker of Disease Severity and Outcome

Table 2

Diagnostic measures and clinical outcomes.

	Nonacute coronary ()	Acute coronary ()	value
Admission unit
ICCU, (%)	0 (0.0)	33 (55.9)	<0.001
Ward, (%)	15 (24.2)	24 (40.7)
Home discharged, (%)	47 (75.8)	2 (3.4)
Cardiac catheterization
Left main, (%)	0 (0.0)	5 (8.5)	0.02
LAD, (%)	0 (0.0)	26 (44.1)	<0.001
Diagonal, (%)	0 (0.0)	12 (20.3)	<0.001
RCA, (%)	0 (0.0)	26 (44.1)	<0.001
Marginal, (%)	0 (0.0)	14 (23.7)	<0.001
Circumflex, (%)	0 (0.0)	15 (25.4)	<0.001
PCI, (%)	0 (0.0)	38 (64.4)	<0.001
CABG	0 (0.0)	4 (6.8)	0.05
Stroke day 30, (%)	3 (4.8)	2 (3.4)	0.68
MI day 30, (%)	0 (0.0)	2 (3.4)	0.14
Death day 30, (%)	0 (0.0)	1 (1.7)	0.34
PCI day 30, (%)	2 (3.2)	15 (25.9)	<0.001
MACE day 30	4 (6.5)	15 (25.4)	0.01
Stroke month 6, (%)	3 (4.8)	2 (3.4)	0.68
MI month 6, (%)	0 (0.0)	4 (6.8)	0.04
Death month 6, (%)	0 (0.0)	1 (1.7)	0.34
PCI month 6, (%)	2 (3.2)	17 (28.8)	<0.001
MACE month 6	4 (6.5)	17 (28.8)	0.01

CVA, MI, cardiac catheterization, or mortality.